论文部分内容阅读
一、口服避孕药(OC) 不远将来,OC 将被一年注射两次的缓慢释放针剂所取代,最近 How-ard G 对于口服及注射甾体避孕制剂作如下的评述:皇家医师学会与药物安全委员会认为减少雌激素和孕激素的含量将成为最安全的口服避孕制剂。复方制剂中,以往注意力集中于雌激素,目前则认为在某些病例中孕激素成份改变了血脂值与增高血压是卒中与缺血性心脏病危险性增加的因素。以后又对孕激素及炔诺酮研究较多。二者除对血脂血压有轻度影响外,对醣代谢也有轻度影响。根据柳叶刀(1981.1.541)报导,延长应用 OC 的时间,
Oral Contraceptives (OC) In the not-too-distant future, OC will be replaced by slow-release injections administered twice a year. How-ard G has recently commented on oral and injectable steroid contraceptives as follows: Royal Society of Physicians and Drugs The safety committee believes reducing estrogen and progestin levels will be the safest oral contraceptives. In compound preparations, previous attention was focused on estrogen, and at the moment it is thought that in some cases the change in serum progesterone levels and increased blood pressure are factors that increase the risk of stroke and ischemic heart disease. After more research on progesterone and norethindrone more. In addition to the two have a slight effect on blood pressure, but also have a mild effect on glucose metabolism. According to the Lancet (1981.1.541) reported that the extension of the application of OC time,